Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-Ichi Miyatake

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Japanese Journal of Clinical Oncology|January 11, 2013
Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PETMotomasa Furuse, Naosuke Nonoguchi, Shinji Kawabata, et al.
Neuro-Oncology Advances|June 21, 2021
Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II studyShinji Kawabata, Minoru Suzuki, Katsumi Hirose, et al.
Journal of Neuro-Oncology|May 24, 2017
Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1<sup>R132H</sup> mutation-negative glioblastomaNatsuko Kondo, Rolf F Barth, Shin-Ichi Miyatake, et al.
Journal of Pharmaceutical Sciences|May 8, 2013
Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2Toshihisa Ishikawa, Yoshinaga Kajimoto, Wei Sun, et al.
Neuro-Oncology|May 13, 2021
Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-upSatoshi Takai, Masahiko Wanibuchi, Shinji Kawabata, et al.
Pharmaceutics|December 7, 2013
Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 InhibitorsToshihisa Ishikawa, Kenkichi Takahashi, Naokado Ikeda, et al.
Journal of Neuro-Oncology|January 25, 2007
Massive apoptotic cell death of human glioma cells via a mitochondrial pathway following 5-aminolevulinic acid-mediated photodynamic therapyHiroto Inoue, Yoshinaga Kajimoto, Masa-Aki Shibata, et al.
Journal of Neurosurgery|October 22, 2003
Transcriptional expression of survivin and its splice variants in brain tumors in humansYoshitaka Yamada, Toshihiko Kuroiwa, Toshimasa Nakagawa, et al.
Life Sciences|February 1, 2003
Over expression of bone morphogenetic protein-3b (BMP-3b) using an adenoviral vector promote the osteoblastic differentiation in C2C12 cells and augment the bone formation induced by bone morphogenetic protein-2 (BMP-2) in ratsShinji Kaihara, Kazuhisa Bessho, Yasunori Okubo, et al.
Radiation Oncology (London, England)|February 12, 2014
The roles of platelet-derived growth factors and their receptors in brain radiation necrosisTomo Miyata, Taichiro Toho, Naosuke Nonoguchi, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Japanese Journal of Clinical Oncology|January 11, 2013
Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PETMotomasa Furuse, Naosuke Nonoguchi, Shinji Kawabata, et al.
Neuro-Oncology Advances|June 21, 2021
Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II studyShinji Kawabata, Minoru Suzuki, Katsumi Hirose, et al.
Journal of Neuro-Oncology|May 24, 2017
Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1<sup>R132H</sup> mutation-negative glioblastomaNatsuko Kondo, Rolf F Barth, Shin-Ichi Miyatake, et al.
Journal of Pharmaceutical Sciences|May 8, 2013
Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2Toshihisa Ishikawa, Yoshinaga Kajimoto, Wei Sun, et al.
Neuro-Oncology|May 13, 2021
Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-upSatoshi Takai, Masahiko Wanibuchi, Shinji Kawabata, et al.
Pharmaceutics|December 7, 2013
Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 InhibitorsToshihisa Ishikawa, Kenkichi Takahashi, Naokado Ikeda, et al.
Journal of Neuro-Oncology|January 25, 2007
Massive apoptotic cell death of human glioma cells via a mitochondrial pathway following 5-aminolevulinic acid-mediated photodynamic therapyHiroto Inoue, Yoshinaga Kajimoto, Masa-Aki Shibata, et al.
Journal of Neurosurgery|October 22, 2003
Transcriptional expression of survivin and its splice variants in brain tumors in humansYoshitaka Yamada, Toshihiko Kuroiwa, Toshimasa Nakagawa, et al.
Life Sciences|February 1, 2003
Over expression of bone morphogenetic protein-3b (BMP-3b) using an adenoviral vector promote the osteoblastic differentiation in C2C12 cells and augment the bone formation induced by bone morphogenetic protein-2 (BMP-2) in ratsShinji Kaihara, Kazuhisa Bessho, Yasunori Okubo, et al.
Radiation Oncology (London, England)|February 12, 2014
The roles of platelet-derived growth factors and their receptors in brain radiation necrosisTomo Miyata, Taichiro Toho, Naosuke Nonoguchi, et al.
Pageof 12